 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

On Thursday, shares of Scopus Biopharma I (NASDAQ: SCPS) experienced volatile short activity. After the activity, the stock price went up +44.85% to $0.3401.
The overall sentiment for SCPS has been Bearish.
read more...

Short Volatility Alert: Scopus Biopharma I

Gainers
Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.

read more...

Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket

NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: SCPS), a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, and its pure-play immuno-oncology subsidiary, Duet BioTherapeutics, today announced that ...

Scopus BioPharma's Subsidiary - Duet BioTherapeutics - Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer

Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharmas Pure Play Immuno-Oncology Subsidiary, Duet BioTherapeutics, Independently Valued at $25 Million Scopus Maintains Approximately 90% Ownership Stake in Duet Duet Being Positioned to Go Public in 2023 NEW YORK, Oct...

Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value

Gainers
Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

read more...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Scopus BioPharma Inc. (NASDAQ:SCPS  Get Rating) was the recipient of a large decrease in short interest in the month of July. As of July 15th, there was short interest totalling 18,600 shares, a decrease of 65.6% from the June 30th total of 54,100 shares. Approximately 0.3% of the company&#...

Scopus BioPharma Inc. (NASDAQ:SCPS) Short Interest Down 65.6% in July

MR Capital Management Inc. acquired a new position in Scopus BioPharma Inc. (NASDAQ:SCPS  Get Rating) during the 1st quarter, according to its most recent filing with the SEC. The fund acquired 76,819 shares of the companys stock, valued at approximately $53,000. MR Capital ...

76,819 Shares in Scopus BioPharma Inc. (NASDAQ:SCPS) Purchased by M&R Capital Management Inc.

Scopus BioPharma Inc. (NASDAQ:SCPS Get Rating) was down 3.9% during mid-day trading on Monday . The stock traded as low as $0.45 and last traded at $0.45. Approximately 73,055 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 254,359 shares. The stock had...

Scopus BioPharma (NASDAQ:SCPS) Stock Price Down 3.9%

---
- Scopus BioPharma Inc. (NASDAQ:SCPS Get Rating) was the target of a significant drop
  in short interest in March. As of March 31st, there was short interest totalling
  75,200 shares, a drop of 23.7% from the March 15th total of 98,600 shares. Based
  on an average daily trading volume, of 322,300 shares...


Scopus BioPharma Inc. (NASDAQ:SCPS) Sees Large Decline in Short Interest

---
- 'Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to Present
  onTLR9 Activation and STAT3 Inhibition: A Bifunctional Approach to Immuno-Oncology
  NEW YORK, March 22, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: SCPS),
  a clinical-stage biopharmaceutical company developing ...'


Scopus BioPharma's Subsidiary - Duet BioTherapeutics - to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit

Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of therapeutics targeting diseases with unmet medical needs. The company was founded on April 18, 2017 and is headquartered in New York, NY.

Watchers	3,186
52-Wk Low	$0.031
52-Wk High	$0.5794

Market Cap	$2.19M
Volume (M)	502.00
52-Wk High	$0.5794
52-Wk Low	$0.031

SCPS Scopus Biopharma Inc

About

Feed

News

Fundamentals